OnCo
peoplePerson

Cheryl L. Willman

Cheryl Willman is a leukaemia genomics pioneer who leads Mayo Clinic's cancer centre across its three sites.

Hematopathologist whose genomic studies defined high-risk subtypes of acute lymphoblastic leukaemia, including work in Hispanic and Native American children. Previously directed the University of New Mexico cancer centre; has led Mayo Clinic Comprehensive Cancer Center since 2021.

Role
Executive Director, Mayo Clinic Comprehensive Cancer Center
Institution
Mayo Clinic
Specialisms
Leukaemia genomicsCancer center leadershipHealth disparities

Papers

2top
TitleJournalYear
Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcomeBlood2010
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemiaNature Genetics2011

Connected

6top

cancers

2
Acute lymphoblastic leukaemiaAcute myeloid leukaemia

technologies

2
Comprehensive genomic profilingRNA sequencing & expression profiling

institutions

2
Mayo ClinicUniversity of New Mexico Comprehensive Cancer Center